Evidence map›Paper›PMID 34448655›Full record

ArticleAnnals of the Royal College of Surgeons of England2021

Sentinel lymph node biopsy with carbon nanoparticle suspension after neoadjuvant chemotherapy for breast cancer patients.

N Wei, J Hou, J Chen, M Dai, K Du, S Wang, Q Ni

Open access · greenAbstract read
In one paragraph

Article in Annals of the Royal College of Surgeons of England, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Cancer theranostics.Nature reviews. Cancer · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Is the ECOG-PS similar to the sarcopenia status for predicting mortality in older adults with cancer? A prospective cohort study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

N WeiGuizhou Provincial People's Hospital, Guiyang, China.
J HouGuizhou Provincial People's Hospital, Guiyang, China.
J ChenGuizhou Provincial People's Hospital, Guiyang, China.
M DaiGuizhou Provincial People's Hospital, Guiyang, China.
K DuGuizhou Provincial People's Hospital, Guiyang, China.
S WangGuizhou Provincial People's Hospital, Guiyang, China.
Q NiGuizhou Provincial People's Hospital, Guiyang, China.
Guizhou Provincial People's Hospital · CNGuiyang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe aim of the study was to explore the feasibility of performing sentinel lymph node biopsy (SLNB) using a carbon nanoparticle suspension (CNPS) after neoadjuvant chemotherapy in breast cancer patients.

methodsSome 152 patients diagnosed with primary breast cancer (cT1-3N0-2M0) were recruited. Patients were divided into two groups according to axillary lymph node (ALN) status after four to six cycles of neoadjuvant chemotherapy. All patients received a CNPS injection, after which SLNB and axillary lymph node dissection (ALND) were performed.

resultsSentinel lymph nodes (SLN) of 143 patients were identified; with an accuracy rate of 94.4% and a false-negative rate of 9.9%. Group A included 67 patients, and the detection, accuracy and false-negative rates within this group were 95.5%, 96.9% and 6.7%, respectively. The corresponding rates for group B (85 patients) were 92.9%, 92.4% and 11.8%, respectively.

conclusionsCNPS is an ideal tracer for improving the detection rate of SLN and can be used to determine SLN status following neoadjuvant chemotherapy.

Indexed as

NanoparticlesAdultAgedAxillaBreast NeoplasmsCarbonFalse Negative ReactionsFemaleHumansMiddle AgedNeoadjuvant TherapyNeoplasm StagingReproducibility of ResultsSentinel Lymph Node BiopsyCarbonBreast cancerCarbon nanoparticle suspensionNeoadjuvant chemotherapySentinel lymph node

Identifiers

PMID34448655
PMCPMC10750766
OpenAlexW3193545560

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.